HF  Rock Springs Capital

http://rockspringscapital.com/





     Office Locations:

650 S. Exeter St., #1070
Baltimore, MD 21202
Phone: 410-220-0130

 

Stages:

  • Early


 

Industries:

  • Life Sciences & Healthcare

  •  

    Description:

    Rock Springs Capital Management is a Baltimore-based hedge fund founded in February 2013 by Kris Jenner. Prior to that, Jenner had spent 14 years working at T. Rowe Price Group, managing its $5.8 billion Health Sciences Fund. Rock Springs is a long/short equity fund specializing in the health care sector. It is currently run by Jenner, Gordon Bussard and Graham Mcphail.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Gordon Bussard Principal
    Graham Mcphail Principal
    Kris Jenner Founder

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      09/29/2023


      Avalyn Pharma


      WA


      $175,000,000


      Series C


      08/21/2023


      Genesis Therapeutics


      CA


      $200,000,000


      Series B


     

    Portfolio companies include:


      3-V Biosciences
        web link


      Adaptive Biotechnologies
        web link


      Aeglea Biotherapeutics
        web link


      Akero Therapeutics
        web link


      Amylyx Pharmaceuticals
        web link


      Aprea Therapeutics
        web link


      Aptinyx
        web link


      Athira Pharma
        web link


      aTyr Pharma


      Aura Biosciences
        web link


      Avalanche Biotechnologies
        web link


      Avalyn Pharma
        web link


      Avenge Bio
        web link


      AveXis


      Bolt Biotherapeutics
        web link


      Braeburn Pharmaceuticals
        web link


      Chiasma
        web link


      Civitas Therapeutics
        web link


      Collegium Pharma
        web link


      Delfi Diagnostics
        web link


      Dermira


      Dimension Therapeutics
        web link


      Disc Medicine
        web link


      ESCAPE Bio
        web link


      Freenome


      G1 Therapeutics


      Galera Therapeutics


      Genesis Therapeutics
        web link


      Hemab Therapeutics
        web link


      Homology Medicines
        web link


      Honor


      Honor Technology
        web link


      Imara
        web link


      Imperative Care


      Inozyme Pharma
        web link


      Invitae


      Kindbody


      Kymera Therapeutics
        web link


      Mersana Therapeutics


      Mirum Pharmaceuticals
        web link


      N30 Pharmaceuticals
        web link


      PulmonX


      resTORbio
        web link


      Spark Therapeutics
        web link


      Spero Therapeutics
        web link


      Theseus Pharmaceuticals
        web link


      TriVascular
        web link


      Vedanta Biosciences
        web link


      Verve Therapeutics
        web link


      Vets First Choice


      Vigil Neuroscience
        web link


      Xilio Therapeutics
        web link


      ­Reneo Pharmaceuticals


     

    Recent News: